Compounds > hyaluronoglucosaminidase
Page last updated: 2024-08-22

hyaluronoglucosaminidase and Local Neoplasm Recurrence

hyaluronoglucosaminidase has been researched along with Local Neoplasm Recurrence in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19901 (5.56)18.7374
1990's3 (16.67)18.2507
2000's8 (44.44)29.6817
2010's4 (22.22)24.3611
2020's2 (11.11)2.80

Authors

AuthorsStudies
Chen, M; Ge, X; Liu, J; Ma, Q; Tang, Y; Wen, Q; Zhang, L; Zhao, M; Zhu, L1
Andersen, H; Anderson-Smits, C; Ay, H; Bar, M; Brannagan, TH; Bril, V; Chroni, E; Duff, K; Greco, E; Hadden, RDM; Hasan, S; Latov, N; Levine, T; Li, Z; Pasnoor, M; Rejdak, K; Rivero, A; Sacconi, S; Souayah, N; Yel, L1
Aslan, G; Bozkurt, O; Mammadov, E; Tuna, B; Yorukoglu, K1
Anttila, M; Kosma, VM; Nykopp, TK; Pasonen-Seppänen, S; Sironen, R; Tammi, MI; Tammi, RH1
Colombo, R1
Duncan, RC; Garcia, A; Golshani, R; Hennenlotter, J; Jorda, M; Knapp, J; Kramer, MW; Kuczyk, MA; Lokeshwar, VB; Merseburger, AS; Soloway, MS; Stenzl, A1
Merseburger, AS1
Damodaran, C1
Gomez, CS; Gomez, P; Jorda, M; Knapp, J; Lokeshwar, VB; Soloway, MS1
Duncan, RC; Hautmann, SH; Lokeshwar, VB; Markowitz, S; Posey, JT; Rose, L; Schroeder, GL; Selzer, MG; Soloway, MS; Watson, R1
Lorenzo Gómez, MF1
Cerwinka, WH; Civantos, F; Duncan, R; Ekici, S; Gomez, P; Lokeshwar, VB; Soloway, MS1
Braun, PM; Eggers, J; Hamann, M; Hautmann, S; Jünemann, KP; Melchior, D; Meyhoff, H; Munk, A; Naumann, M1
Skelton, HG; Smith, KJ; Turiansky, G; Wagner, KF1
Bernhardt, G; Czech, T; Fuiko, R; Hawliczek, G; Köller, U; Nirnberger, G; Pillwein, K; Slavc, I1
Block, NL; Lokeshwar, VB1
Höbarth, K; Maier, U; Marberger, M1
Baumgartner, G; Maier, U1

Reviews

2 review(s) available for hyaluronoglucosaminidase and Local Neoplasm Recurrence

ArticleYear
[The role of tumor markers in urologic consultation for screening, diagnosis, and follow-up of bladder cancer].
    Actas urologicas espanolas, 2003, Volume: 27, Issue:2

    Topics: Antigens, Neoplasm; Biomarkers, Tumor; Female; Flow Cytometry; Follow-Up Studies; Hematuria; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Male; Mass Screening; Neoplasm Proteins; Neoplasm Recurrence, Local; Reagent Kits, Diagnostic; Sensitivity and Specificity; Smoking; Staining and Labeling; Urinalysis; Urinary Bladder Neoplasms; Urine

2003
HA-HAase urine test. A sensitive and specific method for detecting bladder cancer and evaluating its grade.
    The Urologic clinics of North America, 2000, Volume: 27, Issue:1

    Topics: Biomarkers, Tumor; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Neoplasm Recurrence, Local; Sensitivity and Specificity; Urinary Bladder Neoplasms

2000

Trials

2 trial(s) available for hyaluronoglucosaminidase and Local Neoplasm Recurrence

ArticleYear
Hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE-CIDP 1 randomized controlled trial.
    Journal of the peripheral nervous system : JPNS, 2023, Volume: 28, Issue:3

    Topics: Adult; Female; Humans; Hyaluronoglucosaminidase; Immunoglobulins, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Treatment Outcome

2023
Metaphylactic effect of mitomycin C with and without hyaluronidase after transurethral resection of bladder cancer: randomized trial.
    The Journal of urology, 1989, Volume: 141, Issue:3

    Topics: Adult; Aged; Carcinoma, Transitional Cell; Clinical Trials as Topic; Combined Modality Therapy; Double-Blind Method; Female; Humans; Hyaluronoglucosaminidase; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Random Allocation; Urinary Bladder Neoplasms

1989

Other Studies

14 other study(ies) available for hyaluronoglucosaminidase and Local Neoplasm Recurrence

ArticleYear
Hyaluronidase responsive second near-infrared fluorescent nanocomplex for combined HER2 blockade and chemotherapy of HER2+ breast cancer.
    Biomaterials advances, 2022, Volume: 141

    Topics: Animals; Breast Neoplasms; Coloring Agents; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Mice; Neoplasm Recurrence, Local; Paclitaxel; Receptor, ErbB-2; Trastuzumab

2022
Can recurrence and progression be predicted by HYAL-1 expression in primary T1 bladder cancer?
    Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:23

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Cohort Studies; Disease Progression; Female; Humans; Hyaluronoglucosaminidase; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies; Urinary Bladder Neoplasms

2014
Decreased hyaluronidase 1 expression is associated with early disease recurrence in human endometrial cancer.
    Gynecologic oncology, 2015, Volume: 137, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Cell Adhesion Molecules; Endometrial Neoplasms; Female; GPI-Linked Proteins; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Middle Aged; Neoplasm Recurrence, Local

2015
Editorial comment on: HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer.
    European urology, 2010, Volume: 57, Issue:1

    Topics: Biomarkers, Tumor; Disease Progression; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Immunohistochemistry; Muscle, Smooth; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Risk Assessment; Risk Factors; Time Factors; Tissue Array Analysis; Treatment Outcome; Urinary Bladder Neoplasms

2010
HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer.
    European urology, 2010, Volume: 57, Issue:1

    Topics: Aged; Biomarkers, Tumor; Disease Progression; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Immunohistochemistry; Kaplan-Meier Estimate; Logistic Models; Male; Muscle, Smooth; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Tissue Array Analysis; Treatment Outcome; Urinary Bladder Neoplasms

2010
Editorial comment.
    The Journal of urology, 2009, Volume: 182, Issue:4

    Topics: Biopsy; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Male; Neoplasm Recurrence, Local; Predictive Value of Tests; Prostate; Prostatic Neoplasms

2009
Editorial comment.
    The Journal of urology, 2009, Volume: 182, Issue:4

    Topics: Biopsy; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Male; Neoplasm Recurrence, Local; Predictive Value of Tests; Prostate; Prostatic Neoplasms

2009
Hyaluronic acid and HYAL-1 in prostate biopsy specimens: predictors of biochemical recurrence.
    The Journal of urology, 2009, Volume: 182, Issue:4

    Topics: Aged; Biopsy; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prostate; Prostatic Neoplasms

2009
Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid-hyaluronidase and BTA-Stat tests.
    Cancer, 2002, Jul-01, Volume: 95, Issue:1

    Topics: Biomarkers, Tumor; Complement Factor H; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms

2002
Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer.
    International journal of cancer, 2004, Oct-20, Volume: 112, Issue:1

    Topics: Biomarkers, Tumor; Disease Progression; Follow-Up Studies; Glycoproteins; Humans; Hyaluronan Receptors; Hyaluronic Acid; Hyaluronoglucosaminidase; Immunoenzyme Techniques; Male; Microcirculation; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Prognosis; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Sensitivity and Specificity

2004
[Tumor markers for bladder cancer: up-to-date study by the Kiel Tumor Bank].
    Der Urologe. Ausg. A, 2007, Volume: 46, Issue:11

    Topics: Biomarkers, Tumor; Carcinoma in Situ; Carcinoma, Transitional Cell; Cystoscopy; Hematuria; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Neoplasm Staging; Nuclear Proteins; Predictive Value of Tests; Prospective Studies; Urinary Bladder Neoplasms; Urine

2007
Hyaluronidase enhances the therapeutic effect of vinblastine in intralesional treatment of Kaposi's sarcoma. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
    Journal of the American Academy of Dermatology, 1997, Volume: 36, Issue:2 Pt 1

    Topics: Adult; Antineoplastic Agents, Phytogenic; Biopsy; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hyaluronoglucosaminidase; Injections, Intralesional; Male; Middle Aged; Neoplasm Recurrence, Local; Sarcoma, Kaposi; Skin Neoplasms; Vinblastine

1997
Hyaluronidase additional to standard chemotherapy improves outcome for children with malignant brain tumors.
    Cancer letters, 1998, Sep-11, Volume: 131, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Etoposide; Female; Humans; Hyaluronoglucosaminidase; Male; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome

1998
Topical chemoprophylaxis of superficial bladder cancer with mitomycin C and adjuvant hyaluronidase.
    European urology, 1992, Volume: 21, Issue:3

    Topics: Administration, Intravesical; Aged; Carcinoma, Transitional Cell; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Hyaluronoglucosaminidase; Male; Mitomycin; Neoplasm Recurrence, Local; Postoperative Care; Time Factors; Urinary Bladder Neoplasms

1992